Medidata Solutions Inc. (MDSO)

83.70
1.57 1.91
NASDAQ : Technology Services
Prev Close 82.13
Open 82.38
Day Low/High 81.54 / 83.81
52 Wk Low/High 59.60 / 85.92
Volume 655.22K
Avg Volume 612.90K
Exchange NASDAQ
Shares Outstanding 59.22M
Market Cap 4.86B
EPS 0.80
P/E Ratio 110.99
Div & Yield N.A. (N.A)

Latest News

Medidata To Showcase Rave Omics With Biomarker Discovery In Oncology Research At Industry Expert Theater Presentation

Medidata To Showcase Rave Omics With Biomarker Discovery In Oncology Research At Industry Expert Theater Presentation

For the second consecutive year, Medidata (NASDAQ:MDSO) will be presenting its pioneering analytics innovation during the 2018 ASCO Annual Meeting.

PhaseBio Pharma Becomes Medidata's 1,000th Customer, Making Company First In Industry To Achieve This Milestone

PhaseBio Pharma Becomes Medidata's 1,000th Customer, Making Company First In Industry To Achieve This Milestone

Biotech company, PhaseBio Pharmaceuticals, has become Medidata's (NASDAQ:MDSO) 1,000th customer.

Medidata Holds Global Heart Health Awareness Week To Encourage Employee Wellness

Medidata Holds Global Heart Health Awareness Week To Encourage Employee Wellness

Heart disease is the leading cause of death for both men and women. In partnership with the American Heart Association, Medidata (NASDAQ:MDSO) is holding its first annual 'Global Heart Health Awareness' week to provide employees around the world with...

Medidata To Present At The 46th Annual J.P. Morgan Global Technology, Media And Communication Conference

Medidata To Present At The 46th Annual J.P. Morgan Global Technology, Media And Communication Conference

Medidata (NASDAQ:MDSO) today announced that Tarek Sherif, chairman and chief executive officer, will present at the 46th Annual J.

Medidata Offers Breakthrough To De-Risk Clinical Trial Submissions

Medidata Offers Breakthrough To De-Risk Clinical Trial Submissions

To help organizations mitigate the risk of regulatory non-approval and delays, Medidata Solutions (NASDAQ:MDSO) is transforming how clinical trial data is validated prior to FDA submission with Edge Trial Assurance.

Medidata's Melinda Pautsch Named A "Rising Star" By The Healthcare Businesswomen's Association

Medidata's Melinda Pautsch Named A "Rising Star" By The Healthcare Businesswomen's Association

Medidata (NASDAQ: MDSO) is pleased to announce that its director of strategic accounts and medical device/diagnostic sales, Melinda Pautsch, has been named a 2018 "Rising Star" by the Healthcare Businesswomen's Association (HBA).

Medidata To Present At Jefferies 2018 Global Technology Conference

Medidata To Present At Jefferies 2018 Global Technology Conference

Medidata (NASDAQ: MDSO) today announced that Rouven Bergmann, chief financial officer, will present at the Jefferies 2018 Global Technology Conference on Wednesday, May 9, 2018, at 2:30 p.

Idera Pharmaceuticals Increases Operational Efficiency Of Global Oncology Program With Medidata Clinical Cloud

Idera Pharmaceuticals Increases Operational Efficiency Of Global Oncology Program With Medidata Clinical Cloud

Medidata (NASDAQ:MDSO) today announced that Idera Pharmaceuticals, Inc. (NASDAQ:IDRA), expanded its use of the Medidata Clinical Cloud® to automate operations, increase efficiencies, and gain better data visibility in order to accelerate their 2125...

Medidata Edge Strategic Monitoring Wins "Best Sponsor-Focused Technological Development" At CARE Awards 2018

Medidata Edge Strategic Monitoring Wins "Best Sponsor-Focused Technological Development" At CARE Awards 2018

Medidata (NASDAQ: MDSO) is pleased to announce that its risk based monitoring solution, Edge Strategic Monitoring, won an Informa Clinical and Research Excellence (CARE) Award, marking the third consecutive year the company earned this distinction.

Life Science Leaders Discuss Future Of Drug Development At Medidata NEXT London

Life Science Leaders Discuss Future Of Drug Development At Medidata NEXT London

Medidata (NASDAQ: MDSO) is hosting the final European NEXT conference in London this week, with executives presenting from Novartis, aparito, and the global life sciences community.

Medidata Reports First Quarter 2018 Results

Medidata Reports First Quarter 2018 Results

Medidata (NASDAQ:MDSO) today announced its financial results for the first quarter of 2018.

Medidata Schedules First Quarter Earnings Conference Call For April 19, 2018

Medidata Schedules First Quarter Earnings Conference Call For April 19, 2018

Medidata (NASDAQ:MDSO), the leading global provider of cloud-based technology and data analytics for clinical research, today announced that it will release its first quarter 2018 financial results before the open of the...

Australia NHMRC Clinical Trials Centre Partners With Medidata To Digitize Cancer Research

Australia NHMRC Clinical Trials Centre Partners With Medidata To Digitize Cancer Research

Medidata (NASDAQ: MDSO) announced that the National Health and Medical Research Council Clinical Trial Centre (NHMRC CTC), University of Sydney, will now use Medidata's unified platform and analytics for all major new...

FAANG Stocks Aren't the Only Tech Sector Overdue for a Plunge

FAANG Stocks Aren't the Only Tech Sector Overdue for a Plunge

Software stocks have been on fire for several quarters. Now, they could be a overdue for a pullback right along with the FAANG names.

Life Science Leaders Gather At Medidata NEXT Basel And Frankfurt To Examine New Opportunities To Improve Clinical Development And Better Patient Lives

Life Science Leaders Gather At Medidata NEXT Basel And Frankfurt To Examine New Opportunities To Improve Clinical Development And Better Patient Lives

Medidata (NASDAQ:MDSO) successfully hosted NEXT conferences in Basel and Frankfurt, with executives from global life sciences and pharmaceutical companies presenting, including Bayer, Cancer Research UK, and Roche.

How Do Technology And Data Accelerate Precision Medicine In Oncology? Industry Experts To Discuss During Medidata Webinar

How Do Technology And Data Accelerate Precision Medicine In Oncology? Industry Experts To Discuss During Medidata Webinar

Oncology is leading the precision medicine revolution, as clinical researchers leverage and identify biomarkers to target patient subsets with more effective treatments, and the promise of improving Phase I success rate...

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,100 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: ACIW, AMC, CTRP, GSIT, ITGR, JNP, KFFB, MD, MDSO, NJR, VECO Downgrades: NEM, TFX, TTEC Initiations: CNAT, OTEL Read on to get TheStreet Quant Ratings' detailed report:

Medidata To Present At Morgan Stanley Technology, Media & Telecom Conference

Medidata To Present At Morgan Stanley Technology, Media & Telecom Conference

Medidata (NASDAQ:MDSO) today announced that Tarek Sherif, chief executive officer, and Rouven Bergmann, chief financial officer, will present at the Morgan Stanley Technology, Media & Telecom Conference on Wednesday,...

Santen Pharmaceutical To Leverage Medidata Edge CTMS To Drive Future Growth In Ophthalmic Clinical Development

Santen Pharmaceutical To Leverage Medidata Edge CTMS To Drive Future Growth In Ophthalmic Clinical Development

Santen Pharmaceutical Co., Ltd, is expanding its use of the Medidata Clinical Cloud® with the adoption of Edge CTMS (Clinical Trial Management System) to support its clinical trial operations, in...

Medidata And EClinical Solutions LLC Mark 10-Year Anniversary Milestone With Expansion Agreement To Adopt Medical Imaging And Workflow Solutions

Medidata And EClinical Solutions LLC Mark 10-Year Anniversary Milestone With Expansion Agreement To Adopt Medical Imaging And Workflow Solutions

Medidata (NASDAQ: MDSO) today announced that eClinical Solutions LLC, an industry-leading provider of end-to-end data management services and cloud based products for clinical data optimization, is expanding their...

Medidata Named One Of 100 Most Sustainable Companies In The U.S. By Barron's Magazine

Medidata Named One Of 100 Most Sustainable Companies In The U.S. By Barron's Magazine

Medidata (NASDAQ:MDSO) has been named to Barron's first annual list of the " 100 Most Sustainable Companies" in the U.

Aperio Adds Medidata Edge ETMF And CTMS In Expansion Agreement

Aperio Adds Medidata Edge ETMF And CTMS In Expansion Agreement

Aperio, a leading clinical research organization (CRO) formerly known as iNNO Clinical Outcomes, has expanded its use of the Medidata Clinical Cloud ® platform to include Edge eTMF and Edge CTMS, Medidata...

Medidata Clinical Cloud: One Platform For Data Managers, Clinical Operations, Investigators, And Patients To Accelerate The Science And Business Of Research.

Medidata Clinical Cloud: One Platform For Data Managers, Clinical Operations, Investigators, And Patients To Accelerate The Science And Business Of Research.

As clinical trials become more complex, sponsors and contract research organizations (CROs) are looking for a unified platform to help them overcome challenges such as dealing with disparate systems, complying with new...

(Graphic: Business Wire)

(Graphic: Business Wire)

Medidata (NASDAQ:MDSO) announced today that its virtual trials platform, Engage, is now being offered as a part of the Medidata Clinical Cloud®, providing researchers unmatched flexibility to conduct clinical trials...

Medidata Reports Record Full-Year And Fourth Quarter 2017 Results

Medidata Reports Record Full-Year And Fourth Quarter 2017 Results

Medidata (NASDAQ:MDSO) today announced its financial results for the fourth quarter and full year 2017 and provided detailed financial guidance for the full year 2018.

Medidata Clinical Cloud: One Platform For Data Managers, Clinical Operations, Investigators, And Patients To Accelerate The Science And Business Of Research. (Graphic: Business Wire)

Medidata Clinical Cloud: One Platform For Data Managers, Clinical Operations, Investigators, And Patients To Accelerate The Science And Business Of Research. (Graphic: Business Wire)

Targeted therapies create new opportunities for patients, but can require complex trial design to achieve their promise.

Medidata And Syapse Announce Partnership To Bring Oncology Clinical Trials Into Precision Medicine Era

Medidata And Syapse Announce Partnership To Bring Oncology Clinical Trials Into Precision Medicine Era

Partnership will democratize access to clinical trials and help community health systems find and enroll eligible patients at unprecedented scale

Medidata And Syapse Announce Partnership To Bring Oncology Clinical Trials Into Precision Medicine Era

Medidata And Syapse Announce Partnership To Bring Oncology Clinical Trials Into Precision Medicine Era

Medidata (NASDAQ: MDSO), the leading global provider of cloud-based technology and data analytics for clinical research, and Syapse, a market leader in precision medicine solutions, have announced a new partnership to...

TheStreet Quant Rating: B (Buy)